School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
New South Wales Poisons Information Centre, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Drug Saf. 2024 Dec;47(12):1293-1306. doi: 10.1007/s40264-024-01472-y. Epub 2024 Sep 2.
Paracetamol dosing errors can cause acute liver injury, with potentially toxic doses only slightly above the therapeutic range. This study aimed to characterise unintentional paracetamol overdose reported to an Australian poisons centre, including time trends, demographics, types of dosing errors, and outcomes.
Records regarding paracetamol dosing errors for individuals aged ≥12 years were extracted from the New South Wales Poisons Information Centre database, January 2017 to June 2023. Data from 2021 underwent an in-depth screening of free text case notes to examine: dose, duration, products involved, reasons for ingestion and outcomes including hospitalisation, treatment, liver transplantations and deaths. Where possible, complete outcome data were obtained from medical records of New South Wales hospitalised cases in 2021.
There were 14,380 exposures due to paracetamol dosing errors (predominantly self-administered, median age 43 years, 62.6% female), with an average yearly increase of 2.5% (95% CI 1.6-3.8%; p < 0.0001). The in-depth analysis of exposures recorded during 2021 revealed 1899 exposures (median age 46 years, 63.4% female) with 26.8% requiring hospitalisation. Immediate- and modified-release formulations were highly implicated. Multiple paracetamol-containing products were ingested in approximately 20% of exposures. Hospitalised exposures were associated with paracetamol use for dental pain and ingested higher doses for longer durations. Over half of those hospitalised (52%) were treated with the antidote (N-acetylcysteine), and 6% of exposures developed hepatotoxicity.
Paracetamol dosing errors continue to occur, with relatively high rates of hospitalisation and liver injury. Many hospitalisations involved use for dental pain. Possible preventative measures include ingredient name prominence and increased education on appropriate dosing.
对乙酰氨基酚剂量错误可导致急性肝损伤,潜在的有毒剂量仅略高于治疗范围。本研究旨在描述澳大利亚中毒中心报告的非故意对乙酰氨基酚过量,包括时间趋势、人口统计学、剂量错误类型和结果。
从新南威尔士州毒物信息中心数据库中提取 2017 年 1 月至 2023 年 6 月期间年龄≥12 岁的个体因对乙酰氨基酚剂量错误而接受治疗的记录。对 2021 年的数据进行深入筛查,检查了自由文本病例记录中的剂量、持续时间、涉及的产品、摄入原因以及包括住院、治疗、肝移植和死亡在内的结果。尽可能从新南威尔士州 2021 年住院病例的病历中获得完整的结局数据。
因对乙酰氨基酚剂量错误导致 14380 例暴露(主要为自我给药,中位年龄 43 岁,62.6%为女性),年平均增长率为 2.5%(95%CI 1.6-3.8%;p<0.0001)。对 2021 年记录的暴露情况进行深入分析,发现 1899 例暴露(中位年龄 46 岁,63.4%为女性),其中 26.8%需要住院治疗。立即释放和改良释放制剂高度涉及其中。大约 20%的暴露中摄入了多种含对乙酰氨基酚的产品。住院暴露与因牙科疼痛而使用对乙酰氨基酚和摄入更高剂量且持续时间更长有关。住院治疗的暴露者中有一半以上(52%)接受了解毒剂(N-乙酰半胱氨酸)治疗,6%的暴露者发生了肝毒性。
对乙酰氨基酚剂量错误仍在发生,住院和肝损伤的相对发生率较高。许多住院治疗涉及因牙科疼痛而使用对乙酰氨基酚。可能的预防措施包括突出成分名称和增加适当剂量的教育。